Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with mercurial White House ...

US Republican Senator Steve Daines arrived in Bejing on March 20, the first member of Congress to visit China since Trump ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Big Pharma is expected to see big returns from its investment in a class of drugs made famous by Novo Nordisk’s (NVO) popular ...

Kneat's SaaS model automates validation processes in pharma and biotech, reducing errors and ensuring compliance. Learn why ...

For some Big Pharma companies, sales in China contributed to more than 10 percent of global sales, making China a top market ...

Multinational pharmaceutical company AstraZeneca is bullish about China's role as a global innovation powerhouse, underpinned ...

Eli Lilly and Company (NYSE:LLY) offers a quarterly dividend of $1.50 per share and has a dividend yield of 0.71%, as of March 20. It is one of the best dividend stocks on our list as the company has ...

Major American companies have complained to the White House trade office over Labor’s tax crackdown on multinationals amid ...

Investing in TSX healthcare stocks such as Kneat.com can help Canadians generate outsized gains in 2025 and beyond.

Starting at Rs 3,500 per injection, with a monthly cost of up to Rs 14,000, Mounjaro enters India’s growing diabetes and ...